Literature DB >> 17656460

Abnormalities of glucose homeostasis and the hypothalamic-pituitary-adrenal axis in mice lacking hexose-6-phosphate dehydrogenase.

Daniela Rogoff1, Jeffrey W Ryder, Kelli Black, Zheng Yan, Shawn C Burgess, D Randy McMillan, Perrin C White.   

Abstract

Hexose-6-phosphate dehydrogenase (EC 1.1.1.47) catalyzes the conversion of glucose 6-phosphate to 6-phosphogluconolactone within the lumen of the endoplasmic reticulum, thereby generating reduced nicotinamide adenine dinucleotide phosphate. Reduced nicotinamide adenine dinucleotide phosphate is a necessary cofactor for the reductase activity of 11beta-hydroxysteroid dehydrogenase type 1 (EC 1.1.1.146), which converts hormonally inactive cortisone to active cortisol (in rodents, 11-dehydrocorticosterone to corticosterone). Mice with targeted inactivation of hexose-6-phosphate dehydrogenase lack 11beta-hydroxysteroid dehydrogenase type 1 reductase activity, whereas dehydrogenase activity (corticosterone to 11-dehydrocorticosterone) is increased. We now report that both glucose output and glucose use are abnormal in these mice. Mutant mice have fasting hypoglycemia. In mutant primary hepatocytes, glucose output does not increase normally in response to glucagon. Mutant animals have lower hepatic glycogen content when fed and cannot mobilize it normally when fasting. As assessed by RT-PCR, responses of hepatic enzymes to fasting are blunted; enzymes involved in gluconeogenesis (phosphoenolpyruvate carboxykinase, tyrosine aminotransferase) are not appropriately up-regulated, and expression of glucokinase, an enzyme required for glycolysis, is not suppressed. Corticosterone has attenuated effects on expression of these enzymes in cultured mutant primary hepatocytes. Mutant mice have increased sensitivity to insulin, as assessed by homeostatic model assessment values and by increased glucose uptake by the muscle. The hypothalamic-pituitary-adrenal axis is also abnormal. Circulating ACTH, deoxycorticosterone, and corticosterone levels are increased in mutant animals, suggesting decreased negative feedback on the hypothalamic-pituitary-adrenal axis. Comparison with other animal models of adrenal insufficiency suggests that many of the observed abnormalities can be explained by blunted intracellular corticosterone actions, despite elevated circulating levels of this hormone.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17656460     DOI: 10.1210/en.2007-0593

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  17 in total

1.  Contribution of hexose-6-phosphate dehydrogenase to NADPH content and redox environment in the endoplasmic reticulum.

Authors:  Daniela Rogoff; Kelli Black; D Randy McMillan; Perrin C White
Journal:  Redox Rep       Date:  2010       Impact factor: 4.412

2.  G6PT-H6PDH-11βHSD1 triad in the liver and its implication in the pathomechanism of the metabolic syndrome.

Authors:  Ibolya Czegle; Miklós Csala; József Mandl; Angelo Benedetti; István Karádi; Gábor Bánhegyi
Journal:  World J Hepatol       Date:  2012-04-27

3.  Hepatic inflammation induced by high-fructose diet is associated with altered 11βHSD1 expression in the liver of Wistar rats.

Authors:  Ana Vasiljević; Biljana Bursać; Ana Djordjevic; Danijela Vojnović Milutinović; Marina Nikolić; Gordana Matić; Nataša Veličković
Journal:  Eur J Nutr       Date:  2014-01-04       Impact factor: 5.614

4.  Deletion of hexose-6-phosphate dehydrogenase activates the unfolded protein response pathway and induces skeletal myopathy.

Authors:  Gareth G Lavery; Elizabeth A Walker; Nil Turan; Daniela Rogoff; Jeffery W Ryder; John M Shelton; James A Richardson; Francesco Falciani; Perrin C White; Paul M Stewart; Keith L Parker; Daniel R McMillan
Journal:  J Biol Chem       Date:  2008-01-25       Impact factor: 5.157

5.  Impaired oxidoreduction by 11β-hydroxysteroid dehydrogenase 1 results in the accumulation of 7-oxolithocholic acid.

Authors:  Carlos A Penno; Stuart A Morgan; Anna Vuorinen; Daniela Schuster; Gareth G Lavery; Alex Odermatt
Journal:  J Lipid Res       Date:  2013-08-09       Impact factor: 5.922

6.  Evidence that adrenal hexose-6-phosphate dehydrogenase can effect microsomal P450 cytochrome steroidogenic enzymes.

Authors:  Christy A Foster; Gail J Mick; Xudong Wang; Kenneth McCormick
Journal:  Biochim Biophys Acta       Date:  2013-05-09

7.  Hexose-6-phosphate dehydrogenase contributes to skeletal muscle homeostasis independent of 11β-hydroxysteroid dehydrogenase type 1.

Authors:  Nina M Semjonous; Mark Sherlock; Pancharatnam Jeyasuria; Keith L Parker; Elizabeth A Walker; Paul M Stewart; Gareth G Lavery
Journal:  Endocrinology       Date:  2010-11-24       Impact factor: 4.736

8.  Lack of significant metabolic abnormalities in mice with liver-specific disruption of 11β-hydroxysteroid dehydrogenase type 1.

Authors:  Gareth G Lavery; Agnieszka E Zielinska; Laura L Gathercole; Beverly Hughes; Nina Semjonous; Phillip Guest; Khalid Saqib; Mark Sherlock; Gary Reynolds; Stuart A Morgan; Jeremy W Tomlinson; Elizabeth A Walker; Elizabeth H Rabbitt; Paul M Stewart
Journal:  Endocrinology       Date:  2012-05-03       Impact factor: 4.736

9.  Thymic function is maintained during Salmonella-induced atrophy and recovery.

Authors:  Ewan A Ross; Ruth E Coughlan; Adriana Flores-Langarica; Sian Lax; Julia Nicholson; Guillaume E Desanti; Jennifer L Marshall; Saeeda Bobat; Jessica Hitchcock; Andrea White; William E Jenkinson; Mahmood Khan; Ian R Henderson; Gareth G Lavery; Christopher D Buckley; Graham Anderson; Adam F Cunningham
Journal:  J Immunol       Date:  2012-09-19       Impact factor: 5.422

Review 10.  Hepatic growth hormone and glucocorticoid receptor signaling in body growth, steatosis and metabolic liver cancer development.

Authors:  Kristina M Mueller; Madeleine Themanns; Katrin Friedbichler; Jan-Wilhelm Kornfeld; Harald Esterbauer; Jan P Tuckermann; Richard Moriggl
Journal:  Mol Cell Endocrinol       Date:  2012-04-30       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.